Concepedia

Cost effectiveness of palivizumab in children with congenital heart disease in Germany

Mark Nuijten, M. Lebmeier, W Wittenberg

Journal of Medical Economics · 2009 · 22 citations · 25 references

DOI

Abstract

This analysis showed that palivizumab represents a cost-effective means of prophylaxis against severe RSV infection requiring hospitalisation in infants with haemodynamically significant CHD.

References

25

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

Timothy F. Feltes, Allison K. Cabalka, H. Cody Meissner et al. · The Journal of Pediatrics · 2003 · 816 citations

, , +9

Respiratory syncytial virus infection

Eric A. F. Simões · The Lancet · 1999 · 611 citations

, , +4

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

Elaine E. L. Wang, Barbara Law, Derek Stephens · The Journal of Pediatrics · 1995 · 486 citations

, , +11

Survival with congenital heart disease and need for follow up in adult life

Christopher Wren · Heart · 2001 · 371 citations · Full text

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children

Lissette Navas, Elaine Wang, Joan Robinson · The Journal of Pediatrics · 1992 · 357 citations

, , +9